Ikarian Capital LLC 13D/13G Filings for X4 Pharmaceuticals, Inc. (XFOR)

Ikarian Capital LLC 13D and 13G filings for X4 Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-14
11:26 am
Sale		2022-12-3113GX4 Pharmaceuticals, Inc.
XFOR		Ikarian Capital LLC349,133
0.300%		-1,915,358decrease
(-84.58%)		Filing
2022-02-14
4:43 pm
Sale		2021-12-3113GX4 Pharmaceuticals, Inc.
XFOR		Ikarian Capital LLC2,264,491
8.100%		-360,497decrease
(-13.73%)		Filing
2021-04-08
09:02 am
Purchase		2021-03-2313GX4 Pharmaceuticals, Inc.
XFOR		Ikarian Capital LLC2,624,988
11.100%		1,798,564increase
(+217.63%)		Filing
2020-12-30
5:26 pm
Purchase		2020-12-2913GX4 Pharmaceuticals, Inc.
XFOR		Ikarian Capital LLC826,424
5.100%		826,424increase
(New Position)		Filing